Filing Flows

Filing Flows › Amgen (AMGN) › Next earnings date

Amgen (AMGN) earnings: beat the estimate

Amgen (AMGN) reported on Nov 3, 2026 and beat the EPS estimate: $6.45 against $5.78 (+11.6%). Revenue was $10.4B for Q3 2026, +8% year over year. It beat the EPS estimate in 100% of the quarters on record.

Last result+11.6% vs estimate
Beat rate100%

The last report

Amgen reported revenue of $10.4B for the third quarter 2026 (+8% Y/Y), net earnings $3.9B: Product sales $9.9B, BLINCYTO $496M. How it makes money → · Every quarter →

Amgen: EPS against the estimate, last 5 reportsAmgen: EPS against the estimate, last 5 reportsEstimateReported$5.01$5.64Nov 25$4.73$5.29Feb 26$4.77$5.15Apr 26$5.62$6.29Aug 26$5.78$6.45Nov 26
Latest (Nov 26): Estimate $5.78, Reported $6.45.
AMGN: the stock's move on each reportAMGN: the stock's move on each reportAug 4, 2026+7.6%Apr 30, 2026-2.4%Feb 3, 2026+6.2%Nov 4, 2025+8.0%

Amgen's latest quarter

Amgen, Q3 2026: revenue $10.4B (+8% year over year), operating margin 35.8%, net earnings $3.9B, operating cash flow $4.2B. The chart follows the revenue to costs, profit and cash.

Questions

Did Amgen beat earnings?

Amgen (AMGN) reported on Nov 3, 2026 and beat the EPS estimate: $6.45 against $5.78 (+11.6%).

When does AMGN report earnings?

The next date is not set yet.

Does Amgen usually beat earnings?

It beat the consensus EPS estimate in 100% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.